Moreover, SELENOP may induce insulin resistance by affecting adipose tissue to reduce the adiponectin levels [72] or by acting on cultured myotubes with low-density lipoprotein (LDL) receptor-associated protein 1 [73], thereby leading to diabetes. This evidence concerns the gene ADIPOQ and diabetes mellitus.